IVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD.

Size: px
Start display at page:

Download "IVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD."

Transcription

1 Left Main and Bifurcation Summit IVUS-Guided d Provisional i Stenting: ti Plaque or Carina Shift Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea

2 Disclosure I have nothing to disclose

3 IVUS-Guided Provisional Stenting Plaque or Carina Shift Mechanisms of SB Compromise Functional Significance of Jailing Anatomical-Functional Mismatch Pre-PCI Predictors for Functional Jailing

4 Initial Mechanisms of Angiographic SB Jailing Carina Shift After Cross-Over LCX FFR 0.91 Post-stenting

5 Pre-procedural After Cross-Over LCX Carina Shift After cross-over LCX LAD LAD Area Change LCX pullback Lumen -3.4 mm 2 Vessel -3.5 mm 2 LCX pullback Plaque -0.1 mm 2 LCX MLA 7.2 mm 2 LCX MLA 3.8 mm 2 EEM area 9.3 mm 2 EEM area 5.8 mm 2 P+M area 2.1 mm 2 P+M area 2.0 mm 2

6 Mechnisms of Angiographic SB Jaling Plaque Redistribution Pre-procedural Post-stenting After cross-over Area Change Lumen -1.9mm 19mm 2 Vessel -0.4mm 2 LCX MLA 6.9mm 2 Plaque +1.5mm 2 LCX MLA 5.0mm 2 EEM area 9.1mm 2 EEM area 8.7mm 2 P+M 2.2 mm 2 P+M 3.7 mm 2

7 Mechanisms of Angiographic SB Jaliing Stent Strut Artifact Pre-procedural Post-stentingstenting After cross-over over No changes in Lumen or Plaque MLA 8.4mm 2 N MLA 8.3mm 2Novori i

8 Distal MB segment Proximal MB segment Pre Post p Pre Post p Lumen VI 3.5± ±2.1 < ± ±2.0 <0.001 Plaque VI 5.4± ± ± ± Vessel VI 9.0± ±3.1 < ± ±3.5 <0.001 In distal MB, luminal gain is not caused by plaque shift but by vessel enlargement. Carina shift as a result mainly contributes to SB compromise Koo et al. Circ Cardiovasc Interv 2010;3:113-9

9 Changes in LCX Ostial Geometry After a Single Stent Cross-over oeroflmof MLA within LCX Ostium ostium (mm 2 ) LA, LCX M Pre Post-stenting Pre Post % MLA, LCX ostium 5.4mm 2 4.0mm 2 * -20% MLA, LCX carina 6.3mm 2 4.3mm 2 * -31% P+M, LCX ostium 5.2mm 2 5.4mm 2 +4% p=0.009 Eccentricity index * +20% 78% showed >10% reduction in MLA within LCX ostium Kang et al. Circ Cariovasc Interv 2011 Accepted

10 Changes in LCX Ostial Geometry After a Single Stent Cross-over of LM 2 ) EEM area a at the MLA site (mm 2 EEM area at MLA EEM eccentricity P+M area mm 2 9.6mm p=0.048 EE EM eccentric city index at LCX carin na mm 2 5.4mm 2 p< pre post-stenting pre post-stenting 2 ) P+M area a at the ML LA site (mm p=ns pre post-stenting Carina shift is a general mechanism of SB compromise Kang et al. Circ Cariovasc Interv 2011 Accepted

11 Carina Shift Primary Mechanism of SB Compromise MLA, LC CX os (% %) r=0.646 p< MLA, LC CX os (% %) r= p=0.049 % % % EEM area at MLA site(%) Change in EEM eccentricity Kang et al. Circ Cariovasc Interv 2011 Accepted

12 Plaque Redistribution Second Mechanism of SB Compromise P (m mm 2 ) r= p< V / L In minority, P closely plaque correlates redistribution with the may ratio be of superimposed V to L suggesting the larger plaque gain contributes to the greater on carina MLA shift loss to relative lead to to the the further EEM MLA reduction loss Kang et al. Circ Cariovasc Interv 2011 Accepted

13 % LCX carina lum men area a (%) Pre-Procedural Predictor for Anatomical SB Compromise r=0.458 p= Distal carina angle ( ) 160 A narrow distal carina angle between LAD and LCX predicted a greater reduction in MLA as well as EEM area at the LCX ostium Kang et al. Circ Cariovasc Interv 2011 Accepted

14 MACE E-free su urvival α>40 Log-rank p=0.007 α<40 Smaller carina angle predicted higher SB compromise and 1-year MACE rates (also restenosis) Follow-up (months) Gil et al. J Interven Cardiol 2009;22:E1 10

15 IVUS-Guided Provisional Stenting Plaque or Carina Shift Mechanisms of SB Compromise Functional Significance of SB Jailing Anatomical-Functional Mismatch Pre-PCI Predictor for Functional Jailing

16 What is Treatment of Jailed SB Based on, Anatomy or Function? Jailed SB SB intervention 26 lesions 2 lesions No SB intervention 65 lesions 6M Mo f/u No change in SB FFR (0.87± ±0.07) Functional restenosis rate (FFR<0.75) only 8% Koo et al. Eur Heart J 2008;29:726 32

17 No serial changes in SB FFR during 6-month 9-month MACE FFR-guided vs. Conventional FFR-guided provisional SB intervention strategy in bifurcating lesion resulted in a low rate of functional restenosis and 9-month cardiac events Koo et al. Eur Heart J 2008;29:726 32

18 %DS Predicts Neither MLA Nor FFR at the SB Ostium after Cross-overover 2 ) LA of LC CX (mm 2 Post- -stent M 12 r= p= Post-stenting %DS (%) 73% Mismatch Post-stent DS of LCX ostium (%) Kang et al. Circ Cariovasc Interv 2011 Accepted Koo et al. JACC 2005;46: Most lesions (73%) with angiographic g compromise are not functionally significant

19 Anatomical vs. Functional Mismatch SB FFR 0.83 SB MLA 2.6mm 2 SB MLA 1.9mm 2

20 Anatomical vs. Functional Mismatch Pre Post Post-stenting LCX FFR LCX FFR 0.81 LCX-MLA 25mm 2.5mm 2 LCX-MLA 4.2mm 2 LCX-MLA 2.5mm 2

21 Pitfalls of Pre-PCI IVUS vs. FFR of SB Although IVUS assess Anatomical compromise more accurately than QCA, it still has limitations to assess the Functional SB compromise MLA as one of the various anatomical factors FFR is affected by myocardial territory supplied by SB Technical difficulty in obtaining SB-pullback SB FFR?

22 IVUS-Guided Provisional Stenting Plaque or Carina Shift Mechanisms of SB Compromise Functional Significance of Jailing Anatomical-Functional Mismatch Pre-PCI Predictors for Functional Jailing

23 Pre-PCI Angiographic Predictor of Functional Compromise (SB FFR<0.80) OR 95% CI p MB ref MLD MB ref DS SB ref MLD SB %DS Lesion length Carina angle Distal MB MLD Koo et al. Circ Cardiovasc Interv 2010;3:113-9

24 In 90 SB non-lm FFR <0.80: bifurcations 18% post-stenting with SB DS<75%, Independent Predictors for SB FFR β 95% CI p Pre-PCI MLA of SB ostium Pre-PCI PB at SB ostium Pre-PCI PCI MLA of distal MB Maximal balloon pressure Kang et al. Am J Cardiol 2011 in press

25 Pre-procedural IVUS-MLA within SB Ostium Predicts SB FFR <0.80 after MB stenting MLA of SB Ostium Cut-off =2.4mm 2 Sensitivity AUC=0.846 CI p= Specificity it Kang et al. Am J Cardiol 2011 in press SB FFR after cross-ov ver r=0.454 p<0.001 Sensitivity=94% Specificity=68% PPV=40% NPV=98% Pre-PCI MLA within SB ostium (mm 2 ) 32% of SB lesions without functional significance may undergo unnecessary PCI

26 Plaqu ue burden of SB ostium (% %) 80 Only 70 52% FFR< SB FFR<0.80 SB FFR % FFR MLA within SB ostium (mm 2 ) 8 10 Combining pre-pci IVUS-MLA and plaque burden, diagnostic accuracy predicting FFR<0.80 was 83% Kang et al. Am J Cardiol 2011 in press

27 Summary Use of IVUS vs. FFR Pre-procedural Advantage Pitfalls SB-pullback IVUS useful to assess the anatomical severity - MLA, PB, remodeling Predictive value for SB FFR after MB stent MLA-FFR mismatch No IVUS criteria of SB Low feasibility SB FFR functional significance only in isolated SB stenosis, not in true bifurcation Affected by proximal MB or distal SB stenosis SB geometry is usually changed after MB stenting No pre-pci FFR cut-off

28 Summary Use of IVUS vs. FFR After MB Cross-overover Advantage Pitfalls SB-pullback IVUS Mechanism of SB jailing SB MLA MLA-FFR mismatch No IVUS criteria for SB Low feasibility SB FFR Confirm the functional SB compromise Prognostic implication Minority - not feasible Pre-PCI IVUS identifies SB disease and may predict functional SB compromise which is confirmed by post- stenting SB FFR. IVUS provides the precise mechanism

Plaque Shift vs. Carina Shift Prevalence and Implication

Plaque Shift vs. Carina Shift Prevalence and Implication TCTAP 2013 Fellowship Course Left Main and Bifurcation PCI: Bifurcation PCI Plaque Shift vs. Carina Shift Prevalence and Implication Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan

More information

Integrated Use of IVUS and FFR for LM Stenting

Integrated Use of IVUS and FFR for LM Stenting Integrated Use of IVUS and FFR for LM Stenting Gary S. Mintz, MD Cardiovascular Research Foundation Four studies have highlighted the inaccuracy of angiography in the assessment of LMCA disease Fisher

More information

So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea

So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea Anatomical vs Functional Significance? Coronary Angiogram Treadmill Test Tc-99m-MIBI SPECT MDCT Coronary Angiogram

More information

Side Branch Occlusion

Side Branch Occlusion Side Branch Occlusion Mechanism, Outcome, and How to avoid it From COBIS II Registry Hyeon-Cheol Gwon Cardiac&Vascular Center, Samsung Medical Center Sungkyunkwan University School of Medicine SB occlusion

More information

New Insight about FFR and IVUS MLA

New Insight about FFR and IVUS MLA New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR

More information

Between Coronary Angiography and Fractional Flow Reserve

Between Coronary Angiography and Fractional Flow Reserve Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve Seung-Jung Park, MD., PhD. University of Ulsan, College of Medicine Asan Medical Center, Seoul, Korea Visual - Functional

More information

PCI for Left Anterior Descending Artery Ostial Stenosis

PCI for Left Anterior Descending Artery Ostial Stenosis PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary

More information

Left Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD

Left Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD Left Main PCI Integrated Use of IVUS and FFR Seung-Jung Park, MD, PhD Professor of Medicine, University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea Efficacy of Left

More information

Basics of Angiographic Interpretation Analysis of Angiography

Basics of Angiographic Interpretation Analysis of Angiography Basics of Angiographic Interpretation Analysis of Angiography Young-Hak Kim, MD, PhD Cardiac Center, University of Ulsan College of Medicine, Seoul, Korea What made us nervous Supervisors Stent Contrast

More information

FFR-guided Jailed Side Branch Intervention

FFR-guided Jailed Side Branch Intervention FFR-guided Jailed Side Branch Intervention - Pressure wire in Bifurcation lesions - Bon-Kwon Koo, MD, PhD Seoul National University Hospital, Seoul, Korea Bifurcation Lesions Bifurcation Lesions Still

More information

Percutaneous Intervention of Unprotected Left Main Disease

Percutaneous Intervention of Unprotected Left Main Disease Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected

More information

FFR and intravascular imaging, which of which?

FFR and intravascular imaging, which of which? FFR and intravascular imaging, which of which? Ayman Khairy MD, PhD, FESC Associate professor of Cardiovascular Medicine Vice Director of Assiut University Hospitals Assiut, Egypt Diagnostic assessment

More information

Why I try to avoid side branch dilatation

Why I try to avoid side branch dilatation Why I try to avoid side branch dilatation Hyeon-Cheol Gwon Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Why I don t kiss? I kiss! I prefer to discuss SB ballooning rather

More information

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,

More information

Declaration of conflict of interest. Nothing to disclose

Declaration of conflict of interest. Nothing to disclose Declaration of conflict of interest Nothing to disclose Hong-Seok Lim, Seung-Jea Tahk, Hyoung-Mo Yang, Jin-Woo Kim, Kyoung- Woo Seo, Byoung-Joo Choi, So-Yeon Choi, Myeong-Ho Yoon, Gyo-Seung Hwang, Joon-Han

More information

Left Main Intervention: Will it become standard of care?

Left Main Intervention: Will it become standard of care? Left Main Intervention: Will it become standard of care? David Cox, MD FSCAI, FACC Director, Interventional Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown,

More information

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb A. Medina Servicio de Cardiología Hospital Universitario de Gran Canaria Dr. Negrín Islas Canarias (Spain) Provisional

More information

Important LM bifurcation studies update

Important LM bifurcation studies update 8 th European Bifurcation Club 12-13 October 2012 - Barcelona Important LM bifurcation studies update I Sheiban E-mail: isheiban@yahoo.com Unprotected LM Percutaneous Revascularization What is important

More information

ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ

ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ DR ΝΙΚΟΛΑΟΣ ΚΑΥΚΑΣ MD, FESC Διευθυντής, Υπεύθυνος Αιμοδ/κού Εργαστηρίου Καρδιολογική Κλινική Γεν. Νοσοκομείο ΚΑΤ-ΕΚΑ PCI in Coronary Bifurcations Bifurcations

More information

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators

More information

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April Session: Left mains & bifurcation intervention

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April Session: Left mains & bifurcation intervention ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC Seoul, Korea: 25-27 27 April 2007 Session: Left mains & bifurcation intervention An integrated approach to bifurcation lesions: lessons from years of randomized

More information

FFR in Left Main Disease

FFR in Left Main Disease FFR in Left Main Disease William F. Fearon, MD Associate Professor of Medicine Director, Interventional Cardiology Stanford University Medical Center Why FFR instead of IVUS? Physiologic versus anatomic

More information

PCI for Long Coronary Lesion

PCI for Long Coronary Lesion PCI for Long Coronary Lesion Shift of a General Idea with the Introduction of DES In the Bare Metal Stent Era Higher Restenosis Rate With Increasing Stent Length and Decreasing Stent Area Restenosis.6.4.2

More information

Protection of side branch is essential in treating bifurcation lesions: overview

Protection of side branch is essential in treating bifurcation lesions: overview Angioplasty Summit TCT Asia Pacific Seoul, April 26-28, 2006 Protection of side branch is essential in treating bifurcation lesions: overview Alfredo R Galassi, MD, FACC, FSCAI, FESC Head of the Catetherization

More information

as a Mechanism of Stent Failure

as a Mechanism of Stent Failure In-Stent t Neoatherosclerosis e osc e os s as a Mechanism of Stent Failure Soo-Jin Kang MD., PhD. University of Ulsan College of Medicine, Heart Institute Asan Medical Center, Seoul, Korea Disclosure I

More information

Anatomical, physiological and clinical relevance of a side branch

Anatomical, physiological and clinical relevance of a side branch Anatomical, physiological and clinical relevance of a side branch : Which branch really needs a stent? Bon-Kwon Koo, MD, PhD, Seoul, Korea Bifurcation lesion: The GREAT EQUALIZER! No intervention = Balloon

More information

Left Main Intervention: Where are we in 2015?

Left Main Intervention: Where are we in 2015? Left Main Intervention: Where are we in 2015? David A. Cox, MD FSCAI Director, Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown, PA Fall Fellows Course Laa

More information

6 th European Bifurcation Club October BUDAPEST. Kissing in simple strategy? Why and how I kiss. Y. Louvard, ICPS, Massy France

6 th European Bifurcation Club October BUDAPEST. Kissing in simple strategy? Why and how I kiss. Y. Louvard, ICPS, Massy France 6 th European Bifurcation Club 22-23 October 2010 - BUDAPEST Kissing in simple strategy? Why and how I kiss Y. Louvard, ICPS, Massy France A long experience of kissing 1996 Patients 79 Final Kissing balloon

More information

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT01724957 Dobrin Vassilev MD, PhD Assoc. Prof. in Cardiology Head Cardiology Clinic, Alexandrovska University Hospital Medical

More information

Debate Should we use FFR? I will say NO.

Debate Should we use FFR? I will say NO. Debate Should we use FFR? I will say NO. Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol Gwon Research fund from Abbott Korea

More information

Complex Coronary Interventions: Bifurcations. John M. Lasala MD PhD Professor of Medicine Washington University St Louis, Missouri

Complex Coronary Interventions: Bifurcations. John M. Lasala MD PhD Professor of Medicine Washington University St Louis, Missouri Complex Coronary Interventions: Bifurcations John M. Lasala MD PhD Professor of Medicine Washington University St Louis, Missouri Disclosures Advisory Board Boston Scientific, St. Jude Medical Speaker-

More information

Upgrade of Recommendation

Upgrade of Recommendation Challenges in LM PCI Decision-making process for stenting Young-Hak Kim, MD, PhD, Heart Institute, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea Upgrade of Recommendation for

More information

Prognostic Value of Gated Myocardial Perfusion SPECT

Prognostic Value of Gated Myocardial Perfusion SPECT Current Use of IVUS & FFR George D. Dangas, MD, PhD, FACC, FSCAI Professor of Medicine Mount Sinai School of Medicine Prognostic Value of Gated Myocardial Perfusion SPECT 0.6% / year, Cardiac Death and

More information

FFR Fundamentals and Measurements

FFR Fundamentals and Measurements FFR Fundamentals and Measurements Ghassan S. Kassab Thomas Linnemeier Chair Professor Biomedical Engineering, Indiana University Purdue University Indianapolis Principle of FFR Q S ( P P ) / R P max d

More information

Post PCI functional testing and imaging: case based lessons from FFR React

Post PCI functional testing and imaging: case based lessons from FFR React Post PCI functional testing and imaging: case based lessons from FFR React Joost Daemen, MD, PhD, FESC Optics in Cardiology 2018 April 21st, 2018 10.15 10.30h Disclosure Statement of Financial Interest

More information

Left main coronary artery (LMCA): The proximal segment

Left main coronary artery (LMCA): The proximal segment Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1 Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary

More information

LM stenting - Cypher

LM stenting - Cypher LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with

More information

Contemporary therapy of bifurcation lesions

Contemporary therapy of bifurcation lesions Contemporary therapy of bifurcation lesions Dr Angela Hoye MB ChB PhD MRCP Interventional Cardiologist Kingston-upon-Hull, UK Hull The challenge of bifurcations Risk of peri-procedural infarction Relatively

More information

PCI for In-Stent Restenosis. CardioVascular Research Foundation

PCI for In-Stent Restenosis. CardioVascular Research Foundation PCI for In-Stent Restenosis ISR of BMS Patterns of In-Stent Restenosis Pattern I : Focal Type IA: Articulation / Gap Type IB: Marginal Type IC: Focal body Type ID: Multifocal Pattern II,III,IV : Diffuse

More information

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD Onassis Cardiac Surgery Center, Athens, Greece Critical issues in LM PCI Anatomic variability Techniques Variability

More information

Jose Mª de la Torre Hernandez, MD, PhD, FESC. Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander. SPAIN

Jose Mª de la Torre Hernandez, MD, PhD, FESC. Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander. SPAIN Validation and application of IVUS-MLA in LMCA disease Jose Mª de la Torre Hernandez, MD, PhD, FESC Interventional Cardiology Dpt Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander.

More information

OCT guidance for distal LM lesions

OCT guidance for distal LM lesions OCT guidance for distal LM lesions FRANCESCO BURZOTTA INSTITUTE OF CARDIOLOGY CATHOLIC UNIVERSITY OF THE SACRED HEART ROME, ITALY LM suitability for OCT At FU in stented LM Parodi G et al. Eurointervention

More information

LEFT MAIN PERCUTANEOUS CORONARY INTERVENTION. A/Prof Koh Tian Hai Medical Director National Heart Centre, Singapore

LEFT MAIN PERCUTANEOUS CORONARY INTERVENTION. A/Prof Koh Tian Hai Medical Director National Heart Centre, Singapore LEFT MAIN PERCUTANEOUS CORONARY INTERVENTION A/Prof Koh Tian Hai Medical Director National Heart Centre, Singapore Disclosures Advisory Panel, Asian Medical Board Medtronics, Abbott Vascular. Speaker-honoraria,

More information

8 th European Bifurcation Club October Barcelona

8 th European Bifurcation Club October Barcelona 8 th European Bifurcation Club 12-13 October 2012 - Barcelona Jose Mª de la Torre Hernandez, MD, PhD, FESC Interventional Cardiology Dpt Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla

More information

IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation

IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation SURE Trial: Restenosis in non-stented lesions Average of the two image slices with the smallest

More information

Functional Assessment of Jailed Side Branches in Coronary Bifurcation Lesions Using Fractional Flow Reserve

Functional Assessment of Jailed Side Branches in Coronary Bifurcation Lesions Using Fractional Flow Reserve JACC: CARDIOVASCULAR INTERVENTIONS VOL. 5, NO. 2, 2012 2012 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.10.015 Functional

More information

Non-LM bifurcation studies of importance in 2011

Non-LM bifurcation studies of importance in 2011 7th European Bifurcation Club 14-15 October 2011 LISBON Goran Stankovic MD, PhD Non-LM bifurcation studies of importance in 2011 October 15 th : 08:00 08:10 DKCRUSH-II: A Prospective Randomized Trial of

More information

Incidence and Treatment for LM In-Stent

Incidence and Treatment for LM In-Stent Incidence and Treatment for LM In-Stent Restenosis Corrado Tamburino, MD, PhD Full Professor of Cardiology, Director of Postgraduate School of Cardiology Chief Cardiovascular Department, Director Cardiology

More information

STENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

STENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy STENTYS for Le, Main Sten2ng Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement or affilia2on

More information

Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes. Gary S. Mintz, MD Cardiovascular Research Foundation

Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes. Gary S. Mintz, MD Cardiovascular Research Foundation Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes Gary S. Mintz, MD Cardiovascular Research Foundation COURAGE Nuclear Substudy (n=314) Death/MI according the residual ischemia (SPECT)

More information

Bifurcation Stenting. European Bifurcation Club update. Ioannis Iakovou, MD Onassis Cardiac Surgery Center Athens, Greece

Bifurcation Stenting. European Bifurcation Club update. Ioannis Iakovou, MD Onassis Cardiac Surgery Center Athens, Greece Bifurcation Stenting. European Bifurcation Club update. Ioannis Iakovou, MD Onassis Cardiac Surgery Center Athens, Greece The not so new development One vs. two stents General consensus In most bifurcational

More information

Bifurcation stenting with BVS

Bifurcation stenting with BVS Bifurcation stenting with BVS Breaking the limits or just breaking the struts? Maciej Lesiak Department of Cardiology University Hospital in Poznan, Poland Disclosure Speaker s name: Maciej Lesiak I have

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

Intracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington.

Intracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington. Intracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington. Medstar Washington Hospital Center Washington, DC Conflict of Interest None for this

More information

Journal of the American College of Cardiology Vol. 46, No. 5, by the American College of Cardiology Foundation ISSN /05/$30.

Journal of the American College of Cardiology Vol. 46, No. 5, by the American College of Cardiology Foundation ISSN /05/$30. Journal of the American College of Cardiology Vol. 46, No. 5, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.06.009

More information

Drug Eluting Stents: Bifurcation and Left Main Approach

Drug Eluting Stents: Bifurcation and Left Main Approach TCT Asia 2006 Drug Eluting Stents: Bifurcation and Left Main Approach Eberhard Grube MD FACC, FSCAI Heart Center,, Germany Stanford University, School of Medicine, CA, USA DES in High Risk Lesions TAXUS

More information

DK Crush,Culotte,SKS,T or TAP. Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi

DK Crush,Culotte,SKS,T or TAP. Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi PCI for Bifurcations: Which is the best strategy DK Crush,Culotte,SKS,T or TAP Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi CSI 2018 Selection

More information

I have nothing to disclose.

I have nothing to disclose. I have nothing to disclose. ESC congress of cardiology, 25-29th August 2012, Munich, Germany Minsk-Village 6, August 26 th, 2:22 PM Session: The grey zone of coronary interventions: The real bifurcation

More information

CASE from South Korea

CASE from South Korea CASE from South Korea Bon-Kwon Koo, MD, PhD, Seoul, Korea Outpatient clinic of a non-interventional cardiologist F/56 Chief complaint: Angina with recent aggravation, CCS II~III Brief history: # Stroke

More information

LCX. President / Director of Cardiology / New Tokyo Hospital

LCX. President / Director of Cardiology / New Tokyo Hospital LCX President / Director of Cardiology / New Tokyo Hospital Professor of Department of Advanced Cardiovascular Medicine: Kumamoto University Consultant / National Cardiovascular Center / Osaka Sunao Nakamura

More information

Case Review: Borderline LM with IVUS and FFR. Ravi Ramana, DO Heart Care Centers of Illinois SCAI Annual Conference 2010

Case Review: Borderline LM with IVUS and FFR. Ravi Ramana, DO Heart Care Centers of Illinois SCAI Annual Conference 2010 Case Review: Borderline LM with IVUS and FFR Ravi Ramana, DO Heart Care Centers of Illinois SCAI Annual Conference 2010 Disclosures No relevant disclosures. Borderline Left Main Disease Significant LMS

More information

Dr Aniket Puri. OCT guided BVS for LMCA to LAD : Optimising the 'Pot'

Dr Aniket Puri. OCT guided BVS for LMCA to LAD : Optimising the 'Pot' OCT guided BVS for LMCA to LAD : Optimising the 'Pot' Dr Aniket Puri MD,DM,FRACP, FACC, FSCAI, FAPSIC Consultant Interventional Cardiologist Christchurch Hospital and Canterbury DHB(Univ of Otago) Christchurch,New

More information

Bifurcation Stenting: IVUS and OCT Information

Bifurcation Stenting: IVUS and OCT Information Bifurcation Stenting: IVUS and OCT Information Yoshinobu Murasato MD, PhD (New Yukuhashi Hospital) On behalf of J-REVERSE investigators October 14-15, 2011, Lisbon Proximal stent deformation induced by

More information

EBC Rules of Bifurcation PCI

EBC Rules of Bifurcation PCI EBC Rules of Bifurcation PCI Y. Louvard, ICPS, Massy, France What is a coronary bifurcation? «Murray s law» Bifurcation branching laws D1 Murray s law D 3* 3* 3* 1 = D 2 + D 3 D3 Finet s law D 1 = 0.67(D

More information

The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections. Martin B. Leon, MD

The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections. Martin B. Leon, MD The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections Martin B. Leon, MD Columbia University Medical Center Cardiovascular Research Foundation New York City Angioplasty

More information

DESolve NX Trial Clinical and Imaging Results

DESolve NX Trial Clinical and Imaging Results DESolve NX Trial Clinical and Imaging Results Alexandre Abizaid, MD, PhD, Instituto Dante Pazzanese, Sao Paulo, Brazil On behalf of the DESolve Nx Trial Investigators Please refer to the TCT2014 App or

More information

POLish Bifurcation Optimal treatment Strategy randomized Study (POLBOSS) - Interim analysis

POLish Bifurcation Optimal treatment Strategy randomized Study (POLBOSS) - Interim analysis POLish Bifurcation Optimal treatment Strategy randomized Study (POLBOSS) - Interim analysis Robert J. Gil 1,2, MD, PhD, FESC 1- Mossakowski Medical Research Centre, Polish Academy of Sciences 2- Invasive

More information

Although drug-eluting stent implantation for unprotected

Although drug-eluting stent implantation for unprotected Changes in Left Main Bifurcation Geometry After a Single-Stent Crossover Technique An Intravascular Ultrasound Study Using Direct Imaging of Both the Left Anterior Descending and the Left Circumflex Coronary

More information

IVUS vs FFR Debate: IVUS-Guided PCI

IVUS vs FFR Debate: IVUS-Guided PCI IVUS vs FFR Debate: IVUS-Guided PCI Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Disclosure Statement of Financial Interest Within the past 12 months, I have had a financial interest/arrangement

More information

PCI for Ostial Lesion

PCI for Ostial Lesion PCI for Ostial Lesion ii) LAD ostial Osamu Katoh,M.D. kyoto Katsura Hospital Cardiovascular Center PCI for a LAD ostial lesion is well-known to be associated with a high restenosis rate because of excessive

More information

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea IVUS Analysis Myeong-Ki Hong, MD, PhD Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Intimal disease (plaque) is dense and will appear white Media is made of

More information

Stent Fracture and Longitudinal Compression on CT Angiography between the

Stent Fracture and Longitudinal Compression on CT Angiography between the 2014 ASCI Stent Fracture and Longitudinal Compression on CT Angiography between the First- and New-Generation Drug-Eluting Stent Mi Sun Chung, Dong Hyun Yang,Young-Hak Kim, Jae-Hyung Roh, Joon-Won Kang,

More information

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main

More information

Final Kissing Ballooning Returns? The analysis of COBIS II registry

Final Kissing Ballooning Returns? The analysis of COBIS II registry Final Kissing Ballooning Returns? The analysis of COBIS II registry Hyeon- Cheol Gwon Heart Vascular & Stroke Ins?tute, Samsung Medical Center Sungkyunkwan University School of Medicine Final Kissing Ballooning

More information

FFR and IVUS Guided DES Implantation in Long Diffuse Lesions

FFR and IVUS Guided DES Implantation in Long Diffuse Lesions FFR and IVUS Guided DES Implantation in Long Diffuse Lesions Can We Reach Optimal DES Expansion With Conventional Stent Delivery System in Long Diffuse Lesion? Seung-Jea Tahk, MD., PhD. Ajou University

More information

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R 32 ο Πανελλήνιο Καρδιολογικό Συνζδριο, Θεσσαλονίκη 20/10/2011 Gould KL et al, JACC CARDIOVASC IMAG 2009 Gould KL et al AM J CARDIOL 1974 & JACC CARDIOVASC IMAG 2009 Under maximal hyperemia: Rs=Rn FFR=

More information

September Peter Barlis. Royal Brompton Hospital, London, UK

September Peter Barlis. Royal Brompton Hospital, London, UK 3rd EBC Meeting European Bifurcation Club September 2007 PALAU DE LA MUSICA, SalaRodrigo VALENCIA, SPAIN Culotte Technique in Left Main Disease Peter Barlis Carlo DiMario Royal Brompton Hospital, London,

More information

FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria

FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria I would like to express my personal gratitude to Dr. BK Koo for opening

More information

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol

More information

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease

More information

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. In-stent restenosis (ISR) Remains important issue even in the

More information

PCI for Bifurcation Coronary Lesion

PCI for Bifurcation Coronary Lesion PCI for Bifurcation Coronary Lesion Bifurcation Lesions PCI is Challenging Higher acute complication Lower success rates Higher restenosis & TLR Restenosis Rate 21 ~ 57% TLR 8 ~ 43% Event Free Survival

More information

Cardiovascular Research Foundation and Columbia University Medical Center, New York.

Cardiovascular Research Foundation and Columbia University Medical Center, New York. Virtual Histology Intravascular Ultrasound Analysis of Non-culprit Attenuated Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes Xiaofan Wu, Akiko Maehara,

More information

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD Clinical Value of OCT Guidance for Coronary Stenting Giulio Guagliumi, MD 100 % Endovascular Imaging Indications of use 87.5 % 75 % 57.5 % 50 % 45 % 25 % 15 % 0 Lesion morphology Stent optimization Lesion

More information

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE Conflict of interest None to declare While IVUS is the most used intravascular

More information

ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική

ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική X. ΓΡΑΪΔΗΣ Επεμβατικός καρδιολόγος, FSCAI Kλινική Euromedica-Κυανούς Σταυρός, Θεσσαλονίκη The Fear factor The two words LEFT MAIN

More information

SYNTAX score before decision making! Corrado Tamburino, MD, PhD

SYNTAX score before decision making! Corrado Tamburino, MD, PhD SYNTAX score in left main - Tamburino TCT Asia Pacific Seoul, 27 April 2011 Slide 1 SYNTAX score before decision making! Corrado Tamburino, MD, PhD Full Professor of Cardiology, Director of Postgraduate

More information

INTRODUCTION. Catheterization and Cardiovascular Interventions 82: (2013)

INTRODUCTION. Catheterization and Cardiovascular Interventions 82: (2013) Catheterization and Cardiovascular Interventions 82:1075 1082 (2013) Hemodynamic Impact of Changes in Bifurcation Geometry After Single-Stent Cross-over Technique Assessed by Intravascular Ultrasound and

More information

Clinical case in perspective. Cases from Poland

Clinical case in perspective. Cases from Poland Clinical case in perspective Cases from Poland Assoc. Prof. Jacek Legutko, MD, PhD President-Elect of the Association for Percutaneous Cardiovascular Interventions of the Polish Cardiac Society Institute

More information

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Le# main treatment with Stentys stent Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement

More information

Long-term outcomes of simple crossover stenting from the left main to the left anterior descending coronary artery

Long-term outcomes of simple crossover stenting from the left main to the left anterior descending coronary artery ORIGINAL ARTICLE Korean J Intern Med 2014;29:597-602 Long-term outcomes of simple crossover stenting from the left main to the left anterior descending coronary artery Ho-Myung Lee 1,*, Chang-Wook Nam

More information

Prevention of Coronary Stent Thrombosis and Restenosis

Prevention of Coronary Stent Thrombosis and Restenosis Prevention of Coronary Stent Thrombosis and Restenosis Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea 9/12/03 Coronary

More information

Y. Louvard, ICPS, Massy, France. TCT Asia Pacific 2010

Y. Louvard, ICPS, Massy, France. TCT Asia Pacific 2010 Provisional Bifurcation Stenting: Main Branch First Y. Louvard, ICPS, Massy, France TCT Asia Pacific 2010 No conflict of interest to declare M Main prox. first A Main Accross side first D Distal first

More information

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Gary S. Mintz,, MD IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Important IVUS Observations: Remodeling Originally used (first by Glagov) ) to explain atherosclerosis

More information

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future Prof. Juhani Knuuti, MD, FESC Turku, Finland Disclosure: Juhani Knuuti, M.D. Juhani Knuuti, M.D. has financial

More information

Le# Main Interven-on: When Is It Appropriate. Femi Philip, MD Assistant Professor Of Medicine UC Davis

Le# Main Interven-on: When Is It Appropriate. Femi Philip, MD Assistant Professor Of Medicine UC Davis Le# Main Interven-on: When Is It Appropriate Femi Philip, MD Assistant Professor Of Medicine UC Davis Nil Disclosures Outline What is the LMCA? Should we revascularize severe LMCA disease? What revascularizacon

More information

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Disclosures Consultant- St Jude Medical Boston Scientific Speaker- Volcano Corporation Heart

More information

New Generation Drug- Eluting Stent in Korea

New Generation Drug- Eluting Stent in Korea New Generation Drug- Eluting Stent in Korea Young-Hak Kim, MD, PhD Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Purpose To briefly introduce the

More information

Coronary stenting: the appropriate use of FFR

Coronary stenting: the appropriate use of FFR Coronary stenting: the appropriate use of FFR Morton J. Kern, MD Professor of Medicine Chief of Cardiology LBVA Associate Chief Cardiology University California Irvine Orange, California To treat or not

More information

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 Igor F. Palacios, MD Director of Interventional Cardiology Professor of Medicine Massachusetts

More information